Articles with public access mandates - Vamsidhar Velcheti MD FACP FCCPLearn more
Not available anywhere: 4
Challenges faced when identifying patients for combination immunotherapy
MS Ernstoff, S Gandhi, M Pandey, I Puzanov, P Grivas, A Montero, ...
Future Oncology 13 (18), 1607-1618, 2017
Mandates: US National Institutes of Health
A combination of intra-and peritumoral features on baseline CT scans is associated with overall survival in non-small cell lung cancer patients treated with immune checkpoint …
M Khorrami, M Alilou, P Prasanna, P Patil, P Velu, K Bera, P Fu, ...
Medical Imaging 2019: Computer-Aided Diagnosis 10950, 191-199, 2019
Mandates: US Department of Defense, US National Institutes of Health
Compactness measures of tumor infiltrating lymphocytes in lung adenocarcinoma are associated with overall patient survival and immune scores
R Ding, P Prasanna, G Corredor, C Lu, P Velu, K Le, P Leo, N Beig, ...
Medical Imaging 2020: Digital Pathology 11320, 1132003, 2020
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
PD-L1 crosslinking as a new strategy of 4-1BB agonism immunotherapy
F Shu, SR Punekar, V Velcheti, MF Sanmamed, J Wang
Clinical Cancer Research 28 (15), 3182-3184, 2022
Mandates: US National Institutes of Health
Available somewhere: 84
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
F Skoulidis, BT Li, GK Dy, TJ Price, GS Falchook, J Wolf, A Italiano, ...
New England Journal of Medicine 384 (25), 2371-2381, 2021
Mandates: US National Institutes of Health
Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology
K Bera, KA Schalper, DL Rimm, V Velcheti, A Madabhushi
Nature reviews Clinical oncology 16 (11), 703-715, 2019
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Programmed death ligand-1 expression in non-small cell lung cancer
V Velcheti, KA Schalper, DE Carvajal, VK Anagnostou, KN Syrigos, ...
Laboratory investigation 94 (1), 107-116, 2014
Mandates: US National Institutes of Health
Quantitative assessment of the heterogeneity of PD-L1 expression in non–small-cell lung cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA oncology 2 (1), 46-54, 2016
Mandates: US National Institutes of Health
Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
A Drilon, GR Oxnard, DSW Tan, HHF Loong, M Johnson, J Gainor, ...
New England Journal of Medicine 383 (9), 813-824, 2020
Mandates: US National Institutes of Health
In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
KA Schalper, V Velcheti, D Carvajal, H Wimberly, J Brown, L Pusztai, ...
Clinical cancer research 20 (10), 2773-2782, 2014
Mandates: US National Institutes of Health
Radiomics and radiogenomics in lung cancer: a review for the clinician
R Thawani, M McLane, N Beig, S Ghose, P Prasanna, V Velcheti, ...
Lung cancer 115, 34-41, 2018
Mandates: US National Institutes of Health
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
K Bera, N Braman, A Gupta, V Velcheti, A Madabhushi
Nature reviews Clinical oncology 19 (2), 132-146, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs
Objective measurement and clinical significance of TILs in non–small cell lung cancer
KA Schalper, J Brown, D Carvajal-Hausdorf, J McLaughlin, V Velcheti, ...
Journal of the National Cancer Institute 107 (3), dju435, 2015
Mandates: US National Institutes of Health
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ...
The Lancet Oncology 19 (5), 694-704, 2018
Mandates: US National Institutes of Health
Selective RET kinase inhibition for patients with RET-altered cancers
V Subbiah, V Velcheti, BB Tuch, K Ebata, NL Busaidy, ME Cabanillas, ...
Annals of Oncology 29 (8), 1869-1876, 2018
Mandates: US National Institutes of Health
Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
O Gautschi, J Milia, T Filleron, J Wolf, DP Carbone, D Owen, R Camidge, ...
Journal of Clinical Oncology 35 (13), 1403-1410, 2017
Mandates: US National Institutes of Health
Perinodular and intranodular radiomic features on lung CT images distinguish adenocarcinomas from granulomas
N Beig, M Khorrami, M Alilou, P Prasanna, N Braman, M Orooji, S Rakshit, ...
Radiology 290 (3), 783-792, 2019
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis
I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ...
Clinical Cancer Research 25 (15), 4663-4673, 2019
Mandates: US Department of Defense, US National Institutes of Health, Government of …
Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non–small cell lung cancer
M Khorrami, P Prasanna, A Gupta, P Patil, PD Velu, R Thawani, ...
Cancer immunology research 8 (1), 108-119, 2020
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non–small cell lung cancer
G Corredor, X Wang, Y Zhou, C Lu, P Fu, K Syrigos, DL Rimm, M Yang, ...
Clinical cancer research 25 (5), 1526-1534, 2019
Mandates: US Department of Defense, US National Institutes of Health, US Department of …
Publication and funding information is determined automatically by a computer program